This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...
Cosentyx (secukinumab) comes as a subcutaneous injection under the skin or an intravenous (IV) infusion into a vein. Doctors may prescribe it to treat plaque psoriasis, psoriatic arthritis, and other ...
Stelara (ustekinumab) is a brand-name prescription drug approved to treat Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. You should always administer Stelara according ...
Administering Keytruda via subcutaneous injection instead of an intravenous drip.In September 2026, such a drug was approved.
“We want to make sure we are not producing a financial burden for patients in exchange for that convenience [with subcutaneous therapies],” said J. Thaddeus Beck, MD, FACP. A growing number of ...
The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...
The Leqembi (lecanemab) subcutaneous injection pen was approved in Japan on September 16. However, the launch date and drug ...
Subcutaneous mosunetuzumab replaced the IV infusion for patients with R/R LBCL; 57.5% had mostly mild injection-site ...
The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results